Upregulation of integrin expression on monocytes in multiple sclerosis patients treated with natalizumab

被引：6

作者：

Dallari, Simone ^{[1
]}

Franciotta, Diego ^{[2
]}

Carluccio, Silvia ^{[1
]}

Signorini, Lucia ^{[1
]}

Gastaldi, Matteo ^{[2
]}

Colombo, Elena ^{[2
]}

Bergamaschi, Roberto ^{[2
]}

Elia, Francesca ^{[1
]}

Villani, Sonia ^{[1
]}

Ferrante, Pasquale ^{[1
,3
]}

Delbue, Serena ^{[1
]}

机构：

[1] Univ Milan, Dept Biomed Surg & Dent Sci, I-20133 Milan, Italy

[2] Natl Neurol Inst C Mondino, Dept Gen Neurol, Pavia, Italy

[3] Hlth Sci Fdn, Fdn Ettore Sansavini, Lugo, Italy

来源：

JOURNAL OF NEUROIMMUNOLOGY | 2015年 / 287卷

关键词：

Multiple sclerosis; Natalizumab; Monocytes; ANTIBODY NATALIZUMAB; CELLS; MECHANISMS; BIOMARKER; RISK;

D O I：

10.1016/j.jneuroim.2015.08.010

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Natalizumab is a humanized monoclonal antibody against the alpha 4 subunit of VLA-4 integrin that is used to treat conditions such as multiple sclerosis (MS). Although its effects on lymphocytes have been widely described, little is known about its effects on monocytes. Here we described the effects of natalizumab treatment on peripheral blood monocytes from a small cohort of MS patients in terms of relative frequencies and surface integrin (CD49d and CD18) expression. We showed that natalizumab treatment altered the surface integrin expression on monocyte subsets in the peripheral compartment, suggesting a role for them as mediators of natalizumab effects. (C) 2015 Elsevier B.V. All rights reserved.

引用

下载

页码：76 / 79

页数：4

共 50 条

[1] Hypereosinophilia in Patients with Multiple Sclerosis Treated with Natalizumab
LaLive, Patrice
Abbas, Mohamed
Chofflon, Michel
Simon, Hans-Uwe
Chizzolini, Carlo
Ribi, Camillo
NEUROLOGY, 2012, 78
[2] Hypereosinophilia in patients with multiple sclerosis treated with natalizumab
Abbas, M.
Lalive, P. H.
Chofflon, M.
Simon, H. -U.
Chizzolini, C.
Ribi, C.
NEUROLOGY, 2011, 77 (16) : 1561 - 1564
[3] Natalizumab Promotes Activation of Peripheral Monocytes in Patients With Multiple Sclerosis
Frisch, Esther S.
Haeusler, Darius
Weber, Martin S.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 (04):
[4] JCV detection in multiple sclerosis patients treated with natalizumab
Sadiq, Saud A.
Puccio, Lauren M.
Brydon, Edward W. A.
JOURNAL OF NEUROLOGY, 2010, 257 (06) : 954 - 958
[5] Immune surveillance in multiple sclerosis patients treated with natalizumab
Stüve, O
Marra, CM
Jerome, KR
Cook, L
Cravens, PD
Cepok, S
Frohman, EM
Phillips, JT
Arendt, G
Hemmer, B
Monson, NL
Racke, MK
ANNALS OF NEUROLOGY, 2006, 59 (05) : 743 - 747
[6] Binucleated lymphocytes in patients with multiple sclerosis treated with natalizumab
Leclerc, Mathieu
Lesesve, Jean-Francois
Gaillard, Baptiste
Troussard, Xavier
Tourbah, Ayman
Debouverie, Marc
Daliphard, Sylvie
Delmer, Alain
LEUKEMIA & LYMPHOMA, 2011, 52 (05) : 910 - 912
[7] JC virus in multiple sclerosis patients treated with natalizumab
Inmaculacla Dominguez-Mozo, Maria
Alvarez-Lafuente, Roberto
Garcia-Montojo, Marta
De las Heras, Virginia
Manuel Bartolome, Francisco
Arroyo, Rafael
MULTIPLE SCLEROSIS, 2008, 14 : S39 - S39
[8] JC virus in multiple sclerosis patients treated with natalizumab
Dominguez-Mozo, M. I.
Alvarez-Lafuente, R.
Garcia-Montojo, M.
De Las Heras, V.
Bartolome, M.
Garcia-Martinez, A.
Arroyo, R.
MULTIPLE SCLEROSIS, 2009, 15 (09): : S86 - S86
[9] Erythroblastaemia in natalizumab-treated patients with multiple sclerosis
La Gioia, Sara
Seghezzi, Michela
Barcella, Valeria
Dominoni, Paola
Mecca, Tommaso
Frigeni, Barbara
Conti, Marta Zaffira
Vedovello, Marcella
Vidali, Matteo
Rottoli, Mariarosa
Buoro, Sabrina
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 8 : 141 - 144
[10] Outcomes of Iraqi patients with multiple sclerosis treated with natalizumab
Al-Mahdawi, Akram M.
Hatem, Anmar Oday
Mohammed, Omar Tahseen
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP28 - NP28

← 1 2 3 4 5 →